Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediterranean Bioactives is a Greek biotechnology company that specializes in the development and manufacture of high-purity herbal extracts and bioactive compounds for the pharmaceutical, nutraceutical, and cosmeceutical sectors. Founded in 2001 by Maria Papadopoulos, a fourth-generation herbalist, the company is headquartered in Athens with manufacturing operations in Patras. Its signature product, OliveGlow, is a clinically studied blend of astaxanthin and olive leaf extract that has demonstrated a 25% increase in anti-inflammatory efficacy compared to astaxanthin alone. The company utilizes advanced extraction methods, such as supercritical CO2 extraction, to produce pharmaceutical-grade ingredients including 95% pure silymarin from milk thistle. Mediterranean Bioactives is recognized for its integration of traditional Mediterranean botanical knowledge with modern scientific validation and sustainable manufacturing practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediterranean Bioactives.